Waud Capital Partners Completes Sale of PromptCare Infusion to AOM Infusion

Combination creates one of the largest independent home and alternate-site infusion and specialty pharmacy platforms in the country

CHICAGO, Nov. 11, 2026 — Waud Capital Partners ("Waud Capital" or "WCP"), a growth-oriented middle-market private equity firm, today announced that on October 23, 2026, it completed the sale of the infusion and specialty pharmacy business of The PromptCare Companies ("PromptCare Infusion" or the "Company") to AOM Infusion ("AOM"). Terms of the transaction were not disclosed.

PromptCare Infusion provides home and alternate-site infusion therapy and specialty pharmacy services to patients with complex, chronic, and rare conditions. The combination of AOM and PromptCare Infusion establishes a national, scaled infusion platform, bringing together two organizations with a shared history of growth and expansion.

Waud Capital acquired PromptCare in 2021 as part of a Medication-Based Services campaign launched with executive partner Paul Jardina, who has served as PromptCare's Chairman and Chief Executive Officer. During Waud Capital's ownership, the infusion business grew revenue fivefold through organic growth and add-on acquisitions, such as ARJ Infusion Services, PICC Lines Plus, and Coastal Infusion Services. Over the same period, PromptCare Infusion expanded from 19 states to all 50, doubled its pharmacy network to 10 locations, and built a network of 17 ambulatory infusion suites. It also expanded access to national payer and specialty pharmacy networks and built a dedicated commercial and business development organization.

The transaction represents Waud Capital's seventh successful realization in the home and post-acute services sector and its third in infusion services.

"PromptCare Infusion is a clear example of Waud Capital's approach: develop a thesis, partner with an experienced executive before we invest, and build a scaled platform through organic growth and disciplined M&A," said Tim Cremieux, Partner at Waud Capital.

"Paul and the team have built an exceptional clinical organization, and we believe AOM is the right partner for its next chapter," added Chris Graber, Partner and Head of Healthcare at Waud Capital.

"Waud Capital was a true partner in every sense, sharing our vision, investing behind our people, and helping us build a platform that delivers exceptional care to patients with complex needs. We are proud of what we accomplished together and pleased with an outcome that positions PromptCare Infusion and its team for continued success with AOM," said Paul Jardina, Chairman and Chief Executive Officer of PromptCare.

Waud Capital will continue to own PromptCare's complex respiratory and enteral nutrition services business and looks forward to supporting its continued growth.

Media Contact: [email protected] 

SOURCE Waud Capital Partners